AI-Powered Oxygen Therapy: Intelligent FiO2 Titration System for Critical Care
Development of an FDA-compliant AI-powered oxygen therapy system that automatically adjusts FiO2 levels based on real-time SpO2 monitoring and predictive algorithms. Reduces oxygen consumption by 35%, prevents hyperoxia-related complications, and decreases nursing workload while maintaining optimal patient oxygenation.
The Challenge
Manual oxygen titration in hospitals is labor-intensive, often delayed, and frequently results in hyperoxia or hypoxia. A leading medical equipment manufacturer needed an intelligent system to automatically maintain optimal oxygen levels while reducing oxygen waste and nursing workload.
Manual Titration Delays
Nurses check SpO2 and adjust oxygen flow every 1-2 hours. Between checks, patients may experience dangerous oxygen fluctuations that go undetected.
Impact: Delayed intervention riskOxygen Overconsumption
Conservative clinical practice leads to unnecessarily high FiO2 settings. Hospitals waste 30-40% of supplemental oxygen, increasing costs significantly.
Impact: $2M+ annual waste/hospitalHyperoxia Complications
Prolonged high oxygen levels cause lung damage, ROP in premature infants, and increased mortality in some patient populations. Prevention requires precise control.
Impact: Preventable patient harmNursing Workload
ICU nurses spend significant time on manual oxygen adjustments. Automated titration would free them for more critical patient care activities.
Impact: 15% nursing time savedOur Solution
We developed an AI-powered closed-loop oxygen therapy system that continuously monitors SpO2, predicts oxygenation trends, and automatically adjusts FiO2 to maintain target saturation levels - achieving 98.5% time-in-target while reducing oxygen consumption by 35%.
System Architecture
Complete automated oxygen therapy ecosystem with bedside controller, central monitoring, and AI analytics.
Bedside Controller
- High-precision SpO2 monitoring (Masimo SET)
- Proportional oxygen blender valve
- Flow rate sensing (0.1 LPM resolution)
- FiO2 analyzer for delivery verification
- Touch display for manual override
- WiFi + Ethernet connectivity
AI Engine
- Real-time SpO2 trend analysis
- Predictive oxygenation modeling
- PID control with adaptive tuning
- Patient-specific learning
- Anomaly detection and alerts
- Edge inference (< 100ms latency)
Hospital Platform
- Multi-patient monitoring dashboard
- Oxygen consumption analytics
- Clinical decision support
- EMR integration (HL7 FHIR)
- Regulatory audit logging
- Remote specialist consultation
Custom Hardware Design
| MCU | STM32H7 (Safety-critical) |
| SpO2 Module | Masimo SET (motion-tolerant) |
| Oxygen Valve | Proportional solenoid (0-15 LPM) |
| FiO2 Sensor | Paramagnetic (21-100%) |
| Flow Sensor | Mass flow (0.1 LPM resolution) |
| Display | 7" Medical-grade touchscreen |
| Power | Medical PSU + 2hr UPS backup |
| Enclosure | IP54, IEC 60601-1 compliant |
Safety-Critical Firmware (IEC 62304 Class B)
- Dual-core architecture with safety supervisor
- Real-time SpO2 processing at 100 Hz
- Closed-loop control with 200ms cycle time
- Watchdog monitoring with safe-state fallback
- Comprehensive event logging (30-day storage)
- Secure OTA updates with rollback
- Continuous self-test routines
- FDA 21 CFR Part 11 compliant audit trail
Implementation Timeline
Phase 1: Clinical Requirements & AI Research
10 weeks- Clinical workflow analysis in ICUs
- Oxygen therapy protocols review
- AI/ML algorithm research and selection
- Regulatory strategy for AI-based SaMD
Phase 2: Hardware Development
14 weeks- Proportional valve selection and testing
- SpO2 module integration (Masimo SET)
- Safety-critical PCB design
- Enclosure design per IEC 60601
Phase 3: AI Model Development
16 weeks- Training data collection (10,000+ patient hours)
- SpO2 prediction model development
- Adaptive PID controller optimization
- Edge deployment and optimization
Phase 4: Firmware Development
14 weeks- IEC 62304 Class B development process
- Closed-loop control implementation
- Safety monitoring and alarm system
- EMR integration protocols
Phase 5: Verification & Validation
12 weeks- IEC 60601-1 electrical safety testing
- Clinical accuracy study (150 patients)
- AI performance validation
- Usability testing with ICU staff
Phase 6: Regulatory Submission
8 weeks- CE technical file compilation
- AI/ML documentation (GMLP)
- Clinical evaluation report
- Manufacturing validation
Results & Impact
The AI-powered oxygen therapy system has been deployed in 60+ ICUs across India and Europe, significantly reducing oxygen waste while improving patient outcomes through precise oxygenation control.
Oxygen Savings
Reduced consumption vs manual
Time in Target
SpO2 within prescribed range
Response Time
To correct desaturation
Hyperoxia Events
Reduction vs manual care
Nursing Time
Freed for other care
ICUs Deployed
Across India & Europe
“The AI oxygen system has transformed our ICU care. Our nurses no longer spend hours adjusting oxygen flows, and we've virtually eliminated hyperoxia events. The oxygen savings alone paid for the system in 6 months.”
Medical Director, Critical Care
Multi-Specialty Hospital Chain, India
Technologies Used
Related Case Studies
Ready to Build Your Success Story?
Let's discuss how our expertise can help bring your vision to life with measurable results like this project.